Synthes sues Stryker for 'raiding' sales force, misappropriation of secrets

A Synthes ($SYST) unit is accusing rival Stryker ($SYK) of raiding its San Francisco-based sales force and using confidential information from those ex-employees to its advantage.

In a complaint filed in a Philadelphia court, Synthes says three of its former sales employees misappropriated trade secrets and breached their contractual and fiduciary obligations. The employees resigned this year and immediately went to work for Stryker. They are now actively soliciting former customers, Bloomberg cites the filing as saying.

Through its actions, Stryker is attempting to "an improper competitive advantage" in the industry for medical implants and instruments used in spinal surgery, Synthes alleges.

Kalamazoo, MI-based Stryker didn't immediately respond to Bloomberg's requests for comment on the suit.

- get more from Bloomberg

Suggested Articles

About 10 months after first announcing the move, Google has finally subsumed the healthcare-focused efforts of DeepMind.

Amgen has tapped Adaptive Biotechnologies to deliver next-generation sequencing assays as it moves its blood cancer drugs toward approval.

Bayer led One Drop’s $40 million series B round and licensed its technology for its “bio-digital efforts” in areas such as cancer and heart disease.